Table 1 Baseline Characteristics of Supraclavicular Subclavian TAVR patients n = 5

Age, yrs

85 ± 5.0

Female

3 (30.0)

Height, cm

167.9 ± 5.4

Weight, kg

73.3 ± 13.5

STS PROM

4.7 ± 3.2

NYHA functional class III

5 (100.0)

Prior percutaneous coronary intervention

3 (60.0)

Prior coronary artery bypass grafting

1 (20.0)

Prior myocardial infarction

1 (20.0)

Prior stroke

2 (40.0)

Atrial fibrillation

3 (60.0)

Diabetes Mellitus

0 (0.0)

Hypertension

4 (80.0)

History of tobacco use

3 (60.0)

Chronic kidney disease

2 (40.0)

Peripheral arterial disease prohibiting TAVR

5 (100.0)

Chronic lung disease

3 (60.0)

Porcelain aorta

2 (40.0)

Left ventricular ejection fraction, %

62 ± 8.4

Aortic valve area, mm2

0.80 ± 0.17

Aortic valve mean gradient, mmHg

42.4 ± 1.5